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ABSTRACT
Background: Antimicrobial resistance (AMR) is a global public health disaster driven largely
by antibiotic use in human health care. Doctors considering whether to prescribe antibiotics
face an ethical conflict between upholding individual patient health and advancing public
health aims. Existing literature mainly examines whether patients awaiting consultations
desire or expect to receive antibiotic prescriptions, but does not report views of the wider
public regarding conditions under which doctors should prescribe antibiotics. It also does
not explore the ethical significance of public views or their sensitivity to awareness of AMR
risks or the standpoint (self-interested or impartial) taken by participants. Methods: An
online survey was conducted with a sample of the U.S. public (n¼ 158). Participants were
asked to indicate what relative priority should be given to individual patients and society-
at-large from various standpoints and in various contexts, including antibiotic prescription.
Results: Of the participants, 50.3% thought that doctors should generally prioritize individual
patients over society, whereas 32.0% prioritized society over individual patients. When asked in
the context of AMR, 39.2% prioritized individuals whereas 45.5% prioritized society. Participants
were significantly less willing to prioritize society over individuals when they themselves were
the patient, both in general (p ¼ .001) and in relation to AMR specifically (p ¼ .006).
Conclusions: Participants’ attitudes were more oriented to society and sensitive to collective
responsibility when informed about the social costs of antibiotic use and when considered from a
third-person rather than first-person perspective. That is, as participants came closer to taking the
perspective of an informed and impartial “ideal observer,” their support for prioritizing society
increased. Our findings suggest that, insofar as antibiotic policies and practices should be









Antimicrobial resistance (AMR) is a global public
health disaster with significant human and economic
costs. Yearly estimates of the human lives lost to resist-
ant infections have reached 700,000 people globally
(O’Neill 2016) and are expected to exceed 10 million
lives per year by 2050 if no actions are taken against
AMR (O’Neill 2016). Patients with resistant infections
are more likely to develop complications, and are up to
three times more likely to die than patients with nonre-
sistant infections (Cecchini, Langer, and Slawomirski
2015). In the United States alone, AMR accounts for
20 billion USD in excess health service costs annually
(Smith and Coast 2013).
Antibiotic use in human health care is a major
driver of AMR, and an estimated 30% of all outpatient
antibiotic prescriptions in the United States from 2010
to 2011 were found to be inappropriate (Fleming-
Dutra et al. 2016). Formulary restriction (prohibiting
use of particular antibiotics) and preauthorization
requirements have proven effective in reducing antibiotic
prescriptions and resistance rates in inpatient settings
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(Davey et al. 2013; Kaki et al. 2011; Quale et al. 1996).
However, less coercive measures—such as physician edu-
cation and clinical guidelines—have been less successful
(Davey et al. 2013). This may be partly attributable to the
ethical conflict that doctors often face between acting in
the best interests of their patients and acting in the best
interest of society-at-large when considering whether to
prescribe an antibiotic. There is evidence that doctors fre-
quently prioritize individual patient health over public
health when deciding whether to prescribe antibiotics—
even when doing so contravenes clinical guidelines
(Metlay et al. 2002). Many factors contribute to this ten-
dency, but doctors’ perceptions of patient expectations
have been found to strongly correlate with unnecessary
antibiotic prescriptions (Britten and Ukoumunne 1997;
Cockburn and Pit 1997; Coenen et al. 2006; Lado et al.
2008; Macfarlane et al. 1997; Karras et al. 2003).
Although previous studies have found high rates of
patient-reported expectations for antibiotics prior to
their consultation (Britten and Ukoumunne 1997;
Webb and Lloyd 1994; Stivers et al. 2003), it has also
been found that doctors tend to overestimate these
patient expectations, leading to antibiotic prescriptions
that are neither clinically indicated nor expected by
their patients (Lado et al. 2008; Lam, Catarivas, and
Lauder 1995; Macfarlane et al. 1997). This suggests
that doctors may harbor misplaced assumptions about
public expectations for antibiotics. Moreover, even
when patients do expect antibiotics, catering to these
preferences may be incompatible with advancing
patient and/or public health (Gonzales et al. 2001).
Nevertheless, compelling arguments have been made
for giving public views some role in shaping health care.
Some hold that involving citizens in determining health
care goals has intrinsic value and is an integral compo-
nent of democracy (Council of Europe 2000; Department
of Health [UK] 1999; Health Canada 2000; World Health
Organization 1978; Kim et al. 2009; Wait and Nolte
2006). Others assert that public involvement in health
policymaking can reaffirm consumer rights to informa-
tion, access, choice, and redress (Wait and Nolte 2006).
Public engagement in health policymaking may also
result in more resilient policies through increasing public
support (Bruni et al. 2008; World Health Organization
2007; Charles and DeMaio 1993; Williamson 2014;
British Medical Association 2015). Finally, it might be
argued that public attitudes have an evidential role in
determining the ethical acceptability of a health care pol-
icy or practice, for example, because public attitudes can
be expected to converge on, or distribute around, the
most defensible ethical position (Surowiecki 2004);
because it is rational to defer somewhat to one’s peers
when faced with difficult moral quandaries (Nguyen
2010, Rowland 2017); or because health care policy
should reflect the values of citizens (Kitcher 2001).
We suggest that insofar as public attitudes are used
as evidence for ethical acceptability, it is impartial and
informed public views that should be sought. This is
because impartiality is central to ethics, and ethical
judgments grounded on mistaken information are
unjustified. Public views can be considered sufficiently
impartial and informed when members of the public
who are called to express their views become (imper-
fect versions of) “ideal observers.”
To elucidate this expression, we need to invoke the
philosophical tradition of the “ideal observer” in
moral theory. According to ideal observer views, what
people ought to do when faced with an ethical quan-
dary is either determined or evidenced by what people
would do, or would approve of, if they were in ideal
circumstances for rational deliberation (e.g., well-
informed and free of distractions) and regarding the
issue from an impartial point of view (i.e., with an
equal consideration for the preferences and the wel-
fare of all the parties involved) (Hare 1981). For
example, in one influential version of the ideal obser-
ver theory, one ought to do what could be endorsed
by someone who is (1) omniscient about facts, (2)
omnipercipient, (3) disinterested, (4) dispassionate, (5)
consistent, and (6) normal in all other respects
(Brandt 1955, 47; Firth 1952, 31). Of course, no
human being can ever satisfy these conditions
(Harrison 1956, 256). The theory is intended to spe-
cify an ideal. However, we can approximate the condi-
tions to a greater or lesser degree depending, for
example, on how well-informed and impartial we are.
To the extent that we value democratic processes of
policy making for epistemic virtues—that is, because
they tend to result in more justified policies—it would
be desirable that the public’s approach to antibiotic
stewardship was informed by an ethical, rather than a
merely self-interested, perspective.
Unfortunately, published studies of public attitudes
toward doctors’ antibiotic-prescribing practices mainly
encouraged participants to view the issue from a self-
interested rather than impartial perspective by seeking
attitudes towards their own doctors’ prescribing prac-
tices and by studying patients soon to have clinical
consultations rather than members of the wider
public. Participants were also not informed of the
social costs of AMR. Alternatively, previous studies
asked the public about possible strategies to avoid
misuse of antibiotics (Degeling et al. 2018), but not
whether it would be acceptable to prioritize society’s
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interest in the preservation of antibiotic effectiveness
over the individual’s interest in using antibiotics to
treat certain infections.
Our study aims to identify the attitudes that would
be held by members of the public were they to take a
better informed and more impartial perspective—that
is, a perspective that comes closer to that of an ideal




Our survey (see appendix) investigated participants’
opinions on whether medical decisions should favor an
individual patient’s health or collective well-being, in
the case of both general health and AMR in particular.
Participants were given short scenarios that described a
potential conflict between an individual patient’s health
and collective well-being in society and were asked, on a
7-point Likert scale, whether “always the individual”
(value 1) or “always society as a whole” (value 7) should
be prioritized in the given scenario. Scenarios covered
hypothetical decisions in two contexts: a generic, not-
further-specified doctor’s decision concerning a generic
not-further-specified patient; and the participant’s own
doctor’s decision concerning the participant. Both con-
texts were given for the general case and for the case of
AMR, giving a total of four scenarios, which were pre-
sented to participants in random order (see supplemen-
tary materials for all four scenarios). In addition, we
collected demographic information (e.g., age, gender,
ethnicity, socioeconomic status), and participants com-
pleted the Oxford Utilitarianism Scale (OUS) (Kahane
et al. 2018), a validated scale measuring people’s indi-
vidual tendency to endorse utilitarian views, that is,
views according to which morality requires one to
always maximize expected utility impartially. This was
included as some ideal observer theorists have argued
that an “ideal observer” would necessarily be utilitarian
(Hare 1981). The OUS contains two (highly intercorre-
lated) subscales, one indicating people’s endorsement of
impartial beneficence (OUS-IB) and the second their
willingness to accept instrumental harm (OUS-IH) for
the greater good. Our study was reviewed and granted
ethical approval from the University of Oxford’s
Interdivisional Research Ethics Committee.
Recruitment
Amazon MTurk was used to conduct the survey.
Mturk is an online marketplace that allows people to
take part in research online, for a small payment (usu-
ally in accordance with U.S. minimum wage). MTurk
participant samples have been shown to be more rep-
resentative of the general population than college sam-
ples and standard Internet samples often used in
research, and MTurk yields high-quality data that
have been shown to meet or sometimes exceed psy-
chometric standards used in published research
(Buhrmester, Kwang, and Gosling 2011). We aimed to
recruit a minimum of 150 participants.
Results
One hundred and sixty-three U.S.-American partici-
pants took part in our survey online via Amazon
MTurk. Five participants were excluded from data
analysis because they failed attention checks or did
not complete the survey, leaving a total N of 158. We
analyzed the data using SPSS software, checking for
differences depending both on context (generic doctor
vs. own doctor) and on case (general health case
vs. AMR).
Demographics
In our sample, 49% of participants were female, and 51%
were male. They were aged between 20 and 74 years, with
the highest percentage found between 25 and 34 years
(24%). Almost all participants (98%) were from the
United States, and 80% were white. Participants were of a
mixed educational background (e.g., 17% had a high
school diploma as their highest level of education, 28%
attended college, and 38% had a bachelor’s degree), of
mixed relationship status (e.g., 51% single, 49% married
or in marriage-like relationship), and of mixed income
levels (spanning a yearly income between under $5,000
and over $100,000). Most participants self-identified as
“middle class” (48%). Regarding their political views,
most participants considered themselves to be
“moderate/in the middle” (26%) or some degree of liberal
(40%), while the rest stated that they were some degree of
conservative (34%).
With regard to context, participants prioritized society
significantly more when asked what a generic doctor
should do (M¼ 3.65, SD ¼ 1.58) compared to what their
own doctor should do (M¼ 3.30, SD ¼ 1.70), t(157) ¼
3.46, p ¼ .001 in the general case (see Figure 1). Also for
the AMR case, participants thought that generic doctors
should prioritize society more (M¼ 4.04, SD ¼ 1.57)
compared to what their own doctor should do (M¼ 3.79,
SD¼ 1.63), t(157)¼ 2.77, p ¼ .006 (see Figure 1). This is
perhaps not surprising: When people do not know
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whether they would be personally affected by a certain
doctor’s behavior, as in the case of the generic doctor, it
is rational for them to adopt a more impartial perspec-
tive, prioritizing society’s good over an individual’s good.
With regard to case, we found that in both con-
texts, participants thought that society should be pri-
oritized more when they were informed regarding the
costs of AMR and presented with a case involving an
explicit risk of AMR than when asked about the gen-
eral practices of doctors. This was true when partici-
pants were asked what generic doctors should do
(AMR case M¼ 4.04, SD ¼ 1.57; general case
(M¼ 3.65, SD ¼ 1.58); t ¼ (157) ¼ –2.75, p ¼ .007) ,
and what their own doctor should do (AMR case
M¼ 3.79, SD ¼ 1.63; general case M¼ 3.30, SD ¼
1.70; t(157) ¼ –4.00, p < .001).
Regarding participants’ underlying moral views, as
measured by the Oxford Utilitarianism Scale, we
found that the more participants subscribed to utili-
tarian moral views, the more they indicated society
should be prioritized over individual patients in all
questions reported in the preceding (all rs  .195, all
ps  .015). The same pattern held true for both sub-
scales, impartial beneficence (IB; all rs  .140, all ps
 .080) and instrumental harm (IH; all rs  .160, all
ps  .046).
For all core results, we checked for potential differ-
ences across demographic criteria. We did not find
any statistically significant differences depending on
demographics.
Discussion
Which public attitudes should inform medical policy
and practice? As mentioned in the preceding, ideal
observer theory suggests that if public attitudes are to
be given a role in determining or evidencing the eth-
ical acceptability of medical policies and practices, we
should seek the attitudes of better informed and more
impartial observers. Our study suggests that those
observers are likely to be more sympathetic to with-
holding antibiotics than the attitudes of less well-
informed individuals taking a more self-interested
perspective.
We found that participants were significantly more
willing to deem that society should be prioritized in
antibiotic prescription practices when they were made
aware of AMR risks (i.e., when they were provided
with knowledge of relevant facts) and when they were
presented with scenarios framed in third-person terms
(when taking a more impartial perspective). In our
study, participants were made aware of antibiotic risks
through a short educative paragraph (placed between
the abstract and AMR-specific scenarios) that drew a
causal link between antibiotic use and AMR develop-
ment, and indicated the implications of AMR for soci-
ety. We speculate that some participants had a prima
facie objection to forfeiting patient welfare for the
greater good, but were willing to override this objec-
tion when the social costs of antibiotic prescription
were made concrete and salient.
We also found that when considering whether indi-
vidual doctors should prioritize society over individual
patients, participants were significantly more individu-
alistic when they themselves were the patients and their
own health was at stake than when the scenarios were
presented in the third person. This was seen both in
the abstract scenario and in the context of AMR.
These findings suggest that AMR health education
initiatives may benefit from encouraging patients and
the public to form expectations that are more impar-
tial, and providing information about the social costs
of antibiotic use in the form of AMR.
Our study showed that those who scored more
highly on the OUS were more likely to prioritize soci-
ety over self. This is to be expected as utilitarianism
gives impartiality a central place in morality, though it
is not the only theory to do so. If those members of
the public who adopt the perspective of the impartial
observer are best placed to have input into public
Figure 1. Means and standard deviations indicating prioritization of “individuals” or “society” in all four scenarios.
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policy, it could be useful to have a screening tool for
identifying individuals strongly disposed to impartial-
ity. The OUS—and IB in particular—could serve as a
starting point for the development of such a tool,
although it should be refined to accommodate highly
impartialist nonutilitarians. Alternatively, and perhaps
more controversially, if we thought that it would be
more desirable to attain more balance between impar-
tial and impartial perspective in policy processes, and
assuming that a policy process already included a
majority of impartial individuals, the OUS could even
be used to identify those individuals who have less
penchant for impartiality, so that their perspective
could be taken into account during the policy process.
Our study has several limitations. As almost all
participants were U.S. citizens, they would be most
familiar with a fee-for-service health care system, and
may have found withholding individually beneficial
treatment to be less acceptable than in socialized
health care systems (such as in Australia and the
United Kingdom), where rationing is common.
Although balanced (see demographics described ear-
lier), our sample may not be fully representative of
the U.S. population, for example. because all of our
participants were required to have Internet access and
to be users of the MTurk interface. Moreover, while
the differences we report are statistically significant,
the absolute differences on the scale used are often
only small. Furthermore, the scenarios used in our
survey concerned clinically mild and self-limiting
infections, and we cannot generalize to more clinically
severe cases.
Conclusions
Our study provides empirical data on attitudes to
antibiotic prescription of the wider public—rather
than patients awaiting their consultation. It is also the
first to examine the sensitivity of attitudes to aware-
ness of AMR risks and to presentation of scenarios in
terms of the first or third person, and to ask people
about the trade-off between individual interests and
society’s interests. We found that participants were
significantly more willing to prioritize society when
they were made aware of AMR risks and when they
were presented with scenarios framed in the third per-
son. We found significant associations between the
OUS and prioritizing society over self, which probably
reflects a greater orientation to impartiality.
Further empirical studies could be performed exam-
ining doctors’ conceptions of medical virtue and the
extent to which they align their own priorities with
patient welfare or public health aims. The development
of a screening tool for identifying highly impartial pub-
lic participants could be further explored.
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